Tower Research Capital LLC (TRC) - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 6 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$46,855
-89.7%
933
-87.0%
0.00%
-93.3%
Q2 2023$453,270
+444282.4%
7,172
+215.5%
0.02%
+400.0%
Q1 2023$102
+126.7%
2,273
+123.1%
0.00%
+50.0%
Q4 2022$45
-100.0%
1,019
-90.9%
0.00%
-83.3%
Q3 2022$737,000
-6.9%
11,193
-28.6%
0.01%
-33.3%
Q2 2022$792,000
+956.0%
15,679
+1245.8%
0.02%
+1700.0%
Q1 2022$75,000
-74.1%
1,165
-57.0%
0.00%
-80.0%
Q4 2021$290,000
+5.1%
2,708
+0.9%
0.01%
-28.6%
Q3 2021$276,000
+15.5%
2,684
-1.3%
0.01%
+16.7%
Q2 2021$239,000
-59.7%
2,718
-55.4%
0.01%
-40.0%
Q1 2021$593,000
+32.7%
6,093
+52.8%
0.01%
-28.6%
Q4 2020$447,000
-18.3%
3,987
-32.5%
0.01%
+133.3%
Q3 2020$547,000
+7.9%
5,909
-9.1%
0.01%
-71.4%
Q2 2020$507,000
+29.0%
6,497
+32.4%
0.02%
-36.4%
Q4 2019$393,000
+9725.0%
4,906
+8820.0%
0.03%
Q3 2019$4,000
+33.3%
55
+103.7%
0.00%
Q2 2019$3,000
+50.0%
27
+3.8%
0.00%
Q1 2019$2,000
-80.0%
26
-79.5%
0.00%
-100.0%
Q3 2018$10,000
+900.0%
127
+1487.5%
0.00%
Q2 2018$1,000
-99.5%
8
-99.7%
0.00%
-100.0%
Q4 2017$190,000
+1017.6%
2,513
+942.7%
0.02%
+2400.0%
Q3 2017$17,000
+325.0%
241
+52.5%
0.00%
Q4 2016$4,000
-85.7%
158
-89.7%
0.00%
-100.0%
Q1 2016$28,000
+250.0%
1,535
+334.8%
0.00%
+300.0%
Q3 2015$8,0003530.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2023
NameSharesValueWeighting ↓
TRV GP II, LLC 878,875$70,354,00045.87%
CVI Holdings, LLC 200,000$16,010,00015.16%
Foresite Capital Management III, LLC 467,682$37,438,0009.74%
Casdin Capital, LLC 848,648$67,934,0007.46%
BVF INC/IL 564,965$45,225,0005.06%
Ghost Tree Capital, LLC 240,000$19,212,0005.02%
DAFNA Capital Management LLC 119,718$9,583,0004.13%
HHLR ADVISORS, LTD. 1,498,516$119,956,0003.34%
Opaleye Management Inc. 130,000$10,407,0002.88%
Perceptive Advisors 1,271,054$101,748,0002.87%
View complete list of BLUEPRINT MEDICINES CORP shareholders